Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell Transplantation Recipient”

74 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 74 results

Large-scale testing (Phase 3)Study completedNCT02137772
What this trial is testing

Letermovir (MK-8228) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)

Who this might be right for
Prevention of CMV Infection or Disease
Merck Sharp & Dohme LLC 570
Large-scale testing (Phase 3)UnknownNCT04674345
What this trial is testing

Sorafenib Maintenance for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3 Negative Acute Leukemia

Who this might be right for
Acute LeukemiaRelapseHematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University 346
Not applicableNot Yet RecruitingNCT07644481
What this trial is testing

Efficacy and Safety of the CloB2M (Clofarabine Combined With Busulfan and Melphalan) Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients With Acute Myeloid Leukemia in First Complete Remission

Who this might be right for
AML (Acute Myelogenous Leukemia)Allogeneic Hematopoietic Stem Cell Transplantation Recipient
Institute of Hematology & Blood Diseases Hospital, China 30
Testing effectiveness (Phase 2)Study completedNCT03267186
What this trial is testing

Ibrutinib in Preventing Acute Leukemia in Patients After Reduced-Intensity Conditioning and Stem Cell Transplant

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+2 more
Andrew Rezvani 8
Not applicableUnknownNCT00587574
What this trial is testing

Prospective Phase II Study for Assessment of Regulatory Immune Cell Populations After Allogeneic HSCT

Who this might be right for
Allogeneic Hematopoietic Cell Transplant Recipients
Medical University of Vienna 150
Not applicableStudy completedNCT05789615
What this trial is testing

Letermovir Prophylaxis for CMV Infection in Haplo-HSCT Recipients: Single-center Data in China

Who this might be right for
CMV InfectionHematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University 200
Testing effectiveness (Phase 2)Study completedNCT04339062
What this trial is testing

Cemiplimab in AlloSCT/SOT Recipients With CSCC

Who this might be right for
Cutaneous Squamous Cell CarcinomaAdvanced Cancer
Dana-Farber Cancer Institute 12
Not applicableUnknownNCT06242496
What this trial is testing

Brain Abscesses in Transplant Recipients: a Multicentre Retrospective Study (BAT-STUDY)

Who this might be right for
Brain Abscess
Assistance Publique - Hôpitaux de Paris 200
Testing effectiveness (Phase 2)Ended earlyNCT01640301
What this trial is testing

Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant

Who this might be right for
Recurrent Adult Acute Myeloid LeukemiaRecurrent Childhood Acute Myeloid LeukemiaSecondary Acute Myeloid Leukemia+5 more
Fred Hutchinson Cancer Center 47
Not applicableStudy completedNCT00079222
What this trial is testing

Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Cancer
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Temporarily pausedNCT03494569
What this trial is testing

Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia+5 more
City of Hope Medical Center 36
Not applicableNot Yet RecruitingNCT07286461
What this trial is testing

VIROMARKERS GA n.101194735 - CMV and TTV Biomarkers Study Protocol

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientCMV
University of Rome Tor Vergata 290
Testing effectiveness (Phase 2)Ended earlyNCT01629511
What this trial is testing

Allogeneic Stem Cell Transplant for CLL

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientChronic Lymphocytic LeukemiaProlymphocytic Leukemia+1 more
M.D. Anderson Cancer Center 15
Testing effectiveness (Phase 2)Study completedNCT01665677
What this trial is testing

Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Graft vs Host Disease
Mehdi Hamadani 69
Very early researchLooking for participantsNCT03665675
What this trial is testing

Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientCytomegalovirusDonor+2 more
Sumithira Vasu 20
Testing effectiveness (Phase 2)WithdrawnNCT03851081
What this trial is testing

Inotuzumab Ozogamicin and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientBlasts 5 Percent or More of Bone Marrow Nucleated CellsBlasts 5 Percent or More of Peripheral Blood White Cells+5 more
Roswell Park Cancer Institute
Early research (Phase 1)Active Not RecruitingNCT04177004
What this trial is testing

Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplant RecipientHematopoietic and Lymphoid Cell Neoplasm
City of Hope Medical Center 52
Large-scale testing (Phase 3)Study completedNCT00980655
What this trial is testing

Study to Evaluate 13 Valent Pneumococcal Conjugate Vaccine (13vPnC) Vaccine Followed by 23-valent Pneumococcal Polysaccharide Vaccine (23vPS) Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Who this might be right for
Vaccines, Pneumococcal Conjugate Vaccine
Pfizer 251
Testing effectiveness (Phase 2)Looking for participantsNCT07214688
What this trial is testing

Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies

Who this might be right for
Allogeneic Stem Cell Transplant Recipient
Hackensack Meridian Health 209
Early research (Phase 1)Study completedNCT04220684
What this trial is testing

Trial Testing Safety of IL-21 NK Cells for Induction of R/R AML

Who this might be right for
Allogeneic Stem Cell Transplant RecipientBlasts 10 Percent or More of Bone Marrow Nucleated CellsRecurrent Acute Myeloid Leukemia+1 more
Sumithira Vasu 19
Next Page